Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduced-intensity allogeneic transplantation for myeloma: reality bites.

Literature DB >> 19342498

Reduced-intensity allogeneic transplantation for myeloma: reality bites.

A Keith Stewart¹.
1. Mayo Clinic, USA.

Abstract

Entities: Disease

Year: 2009 PMID： 19342498 DOI： 10.1182/blood-2008-12-173526

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.

Authors: Nilanjan Ghosh; Xiaobu Ye; Hua-Ling Tsai; Javier Bolaños-Meade; Ephraim J Fuchs; Leo Luznik; Lode J Swinnen; Douglas E Gladstone; Richard F Ambinder; Ravi Varadhan; Satish Shanbhag; Robert A Brodsky; Ivan M Borrello; Richard J Jones; William Matsui; Carol Ann Huff
Journal: Biol Blood Marrow Transplant Date: 2017-07-12 Impact factor: 5.742

Review 2. A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma?

Authors: Damian J Green; William I Bensinger
Journal: Curr Hematol Malig Rep Date: 2017-02 Impact factor: 3.952

3. Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management

Authors:
Journal: Am J Hematol Date: 2018-08-16 Impact factor: 10.047

4. Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

Authors: Damian J Green; David G Maloney; Barry E Storer; Brenda M Sandmaier; Leona A Holmberg; Pamela S Becker; Min Fang; Paul J Martin; George E Georges; Michelle E Bouvier; Rainer Storb; Marco Mielcarek
Journal: Blood Adv Date: 2017-11-09

5. Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management.

Authors: S Vincent Rajkumar
Journal: Am J Hematol Date: 2012-01 Impact factor: 10.047

6. Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.

Authors: I Ahmad; R LeBlanc; S Cohen; S Lachance; T Kiss; G Sauvageau; D C Roy; L Busque; J-S Delisle; N Bambace; L Bernard; W Sabry; J Roy
Journal: Bone Marrow Transplant Date: 2015-12-21 Impact factor: 5.483

7. Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma.

Authors: Yvonne A Efebera; Sofia R Qureshi; Suzanne M Cole; Rima Saliba; Matteo Pelosini; Ronak M Patel; Ebru Koca; Floralyn L Mendoza; Michael Wang; Jatin Shah; Amin Alousi; Chitra Hosing; Uday Popat; Partow Kebriaei; Paolo Anderlini; Issa F Khouri; Richard Champlin; Sergio Giralt; Muzaffar H Qazilbash
Journal: Biol Blood Marrow Transplant Date: 2010-02-21 Impact factor: 5.742